anti-glycan scFv antibodies
glycan interactions
engineer glycan recognition molecules
glycan recognition capabilities
roles of anti-glycan recognition molecules
anti-glycan antibody engineering
glycan-based therapeutics
specificity of anti-Î±Gal scFv
scFv domains
affinity-wise
affinity-measurement
validation of computational models of scFv
carbohydrate molecules
mutations
workflow
best
SUGARSmart
major aims
development of new approaches
Smart design of recombinant antibody fragments specific
well-established approaches
array techniques
experimental techniques
chain shuffling
major challenge
rational design of single
chain fragment variable
wide computational pipeline
tailored development of future diagnostic reagents
potential application
coherent framework
immunity
SPR
lectins
physio- pathological conditions
diverse role of glycans
hyperacute rejection
cancer
cell
particular locations
ITC
ability
diagnosis of diseases
previous research
bioprosthetic transplantation
mutagenesis
important sites
order
structural complexity
detection limits of assays
interdisciplinary approach
attempt
ELISA
experiments
end
range of mutational strategies
project
predicted mutants
molecular modeling
knowledge
predictions
Validity
issues